Investor Overview
A biotechnology platform built for high-value biological ingredients.
Anneo operates at the intersection of several of the fastest-growing sectors in the global economy. The global probiotics and microbiome markets are expanding rapidly, driven by rising health awareness, ageing populations, and a global shift toward preventive, science-backed wellness.
Anneo is building a vertically capable platform - from strain and fermentation to finished biological ingredients - designed to participate meaningfully in this growth.
- Biotechnology
- Human Health & Wellbeing
- Microbiome Science
- Functional Nutrition
- Preventive Healthcare
- Biological Innovation
Why Anneo
New investor framing for a scalable biotech platform.
Platform, Not Product
Multiple ingredient categories across a single fermentation and quality backbone.
High-Value Science
A deliberate focus on differentiated, premium, defensible ingredients.
Global Market
International demand across pharma, nutraceutical, and functional food.
Built for Scale
Quality systems and documentation designed for export and institutional partnership from day one.
Investor enquiries and information
For investor enquiries, partnership discussions, and additional information, contact the Anneo business team.